ArticleAntimicrobial resistance and infection control2025
Implementation of a multimodal strategy via a mobile application to reduce catheter failure in patients with vascular access devices in Spain (CUIDAVEN Study): a pre-post intervention study.
Article in Antimicrobial resistance and infection control, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundTwo billion vascular access devices (VADs) are used each year worldwide for the administration of intravenous therapy. Among the most serious complications are catheter-related bloodstream infections (CRBSIs), which increase morbidity and mortality and reduce patients' quality of life. The aim of this study was to evaluate the impact of implementing a multimodal intervention through a mobile application (CUIDAVEN, Nursing-led Vascular Access Care) on reducing catheter failure and the healthcare costs associated with CRBSIs, while improving nurses' adherence to best practice recommendations for vascular access care.
methodsWe conducted a quasi-experimental pre-post intervention study without a control group, from April 2019 to August 2022, at the Hospital Regional University of Málaga (Spain). Adult patients requiring VADs (short peripheral intravenous catheters, midlines, peripherally inserted central catheter, and centrally inserted central catheters) for intravenous therapy and capable of using a mobile application were included. Patients with cognitive impairment or in a terminal condition were excluded. The intervention involved the use of the CUIDAVEN mobile application, which provided educational resources, reminders, and monitoring tools. Data were collected during the pre- and post-intervention phases. Variables analysed included sociodemographic characteristics, adherence to good practices, health outcomes, and resource consumption.
resultsA total of 378 patients and 968 VADs were analysed. Catheter failure rate decreased by 19.42% in the post-intervention phase (from 16.95% to 12.24%), with an 80% reduction in CRBSIs (from 2.30% to 0.61%). Mean cost per complication fell from €310.66 to €118.79 (p=0.007). Significant improvements were observed in adherence to best practices. Patients also reported increased knowledge and satisfaction with the use of CUIDAVEN.
conclusionsThe implementation of the CUIDAVEN mobile application was associated with a reduction in both infectious and non-infectious complications and improved adherence to recommended practices. Patients perceived greater knowledge and satisfaction, highlighting the potential of digital health tools to empower individuals and improve health outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.